Plain-English translation of NCT06713512 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how estrogen — a hormone that women have in higher levels than men — affects lung health in people with asthma or COPD. This is an observational study, meaning researchers will follow you over time and compare changes in your hormone levels, lung function, and immune system rather than giving you a new treatment. The study includes both people with lung disease and healthy people without it.
Women are more likely to die from asthma and COPD than men, and scientists believe sex hormones like estrogen may explain this difference. This research could help doctors better understand and treat lung disease in women, especially around menopause when estrogen levels drop naturally.
You likely qualify if…
You likely don't qualify if…
You will attend baseline visits and follow-up visits over 12 to 24 months (depending on which study stream you choose). At these in-person visits, you will provide blood samples, answer questionnaires about your health and symptoms, and have your lung function tested. The researchers will track changes in your hormone levels, immune system response, and lung health over time, comparing these changes between people with and without lung disease, and between women at different life stages.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United Kingdom